Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyHydrogen-rich saline

Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress.

Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ · Brain research · 2010

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Alzheimer’s Disease
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Hydrogen-rich saline
hydrogen-rich saline alzheimer’s disease study 2010 research summary

The publication “Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress.” is organized in H2HUBB under the research focus hydrogen-rich saline alzheimer’s disease study 2010. The publication is cited as Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ, Brain research, 2010. This animal study examined Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress. The abstract describes Rat model; sample size 84; hydrogen delivered as hydrogen-rich saline and injected or infused hydrogen; reported duration 14 days. This is an automated editorial draft based on the abstract and requires source review before publication.

Hydrogen-rich saline alzheimer’s disease study 2010 overview

The levels of MDA, IL-6 and TNF-alpha were assessed by biochemical and ELISA analysis. Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.

Study design and hydrogen intervention

Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Rat model. Sample size: 84. Blinding: Unknown. Control status: Unknown.

Delivery method: Hydrogen-rich saline. Dose or treatment amount: 330g. Treatment duration: 14 days.

Reported findings and scientific interpretation

For this hydrogen-rich saline alzheimer’s disease study 2010, the study record reports the following: No detailed finding statement was available for this record. Readers should consult the original publication before drawing conclusions.

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: Preclinical animal findings may not translate directly to human outcomes.
The intervention or follow-up period appears relatively short.

Safety: The abstract did not provide detailed safety or adverse-event information.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.